Advertisement

Long-Term Review of Penetrating Keratoplasty: A 20-Year Review in Asian Eyes

Published:October 27, 2020DOI:https://doi.org/10.1016/j.ajo.2020.10.014

      Purpose

      To review the long-term outcomes of optical, therapeutic and tectonic forms of penetrating keratoplasty over a 20-year period in Asian eyes.

      Design

      Prospective cohort study involving the Singapore Corneal Transplant Study (SCTS).

      Methods

      All penetrating keratoplasties (PK) performed at the Singapore National Eye Centre (SNEC) from January 1991 to December 2010 were analyzed using records from the computerized database of the SCTS. This database includes preoperative, intraoperative, and postoperative patient data and donor cornea data. Only primary grafts were included. Patient demographics, donor cornea source, indications for grafting, complications, graft survival rate, and causes of graft failure were analyzed.

      Results

      A total of 1,206 primary PKs were performed. The mean age of the patients was 55 years (range: <1-101 years). The overall corneal graft survival rates at 1, 5, 10, 15, and 20 years were 91%, 66.8%, 55.4%, 52%, and 44%, respectively. For optical grafts, pseudophakic bullous keratopathy, postinfectious corneal scarring and thinning and keratoconus were the most common diagnoses. Graft survival for optical grafts was significantly better than therapeutic and tectonic grafts at all time points. Multivariate analysis suggested that a younger donor cornea age and higher donor endothelial cell count are associated with better long-term graft survival for optical grafts. Irreversible allograft rejection and late endothelial failure accounted for more than 60% of graft failures.

      Conclusions

      Graft survival decreased over time from 91% at 1 year to 44% at 20 years' follow-up. Allograft rejection and late endothelial failure accounted for more than 60% of graft failures.
      To read this article in full you will need to make a payment

      References

        • Wolfe R.A.
        • Roys E.C.
        • Merion R.M.
        Trends in organ donation and transplantation in the United States, 1999-2008.
        Am J Transplant. 2010; 10: 961-972
        • Joss N.
        • Rodger R.S.
        • McMillan M.A.
        • Junor B.J.
        Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
        Transplantation. 2007; 83: 582-587
        • Jahansouz C.
        • Jahansouz C.
        • Kumer S.C.
        • Brayman K.L.
        Evolution of β-cell replacement therapy in diabetes mellitus: islet cell transplantation.
        J Transplant. 2011; 2011: 247959
        • Williams K.A.
        • Esterman A.J.
        • Bartlett C.
        • Holland H.
        • Hornsby N.B.
        • Coster D.J.
        How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis.
        Transplantation. 2006; 27: 896-899
        • Borderie V.M.
        • Boëlle P.Y.
        • Touzeau O.
        • Allouch C.
        • Boutboul S.
        • Laroche L.
        Predicted long-term outcome of corneal transplantation.
        Ophthalmology. 2009; 116: 2354
        • Tan D.T.H.
        • Janardhanan P.
        • Zhou H.
        • et al.
        Penetrating keratoplasty in Asian eyes. The Singapore Corneal Transplant Study.
        Ophthalmology. 2008; 115: 975-982
        • Wong T.Y.
        • Chan C.
        • Lim L.
        • Lim T.H.
        • Tan D.T.
        Changing indications for penetrating keratoplasty: a newly developed country’s experience.
        Aust N Z J Ophthalmol. 1997; 25: 145-150
        • Mannis M.J.
        • Holland E.J.
        • Gal R.L.
        • et al.
        • Writing Committee for the Cornea Donor Study Research Group
        The effect of donor age on penetrating keratoplasty for endothelial disease: graft survival after 10 years in the cornea donor study.
        Ophthalmology. 2013; 120: 2419-2427
        • Nishimura J.K.
        • Hodge D.O.
        • Bourne W.M.
        • et al.
        • Cornea Donor Study Investigator Group
        Initial endothelial cell density and chronic endothelial cell loss rate in corneal transplants with late endothelial failure.
        Ophthalmology. 1999; 106: 1962-1965
        • Lass J.H.
        • Sugar A.
        • Benetz B.A.
        • et al.
        • Writing Committee for the Cornea Donor Study Research Group
        Cornea Donor Study Investigator Group. Endothelial cell density to predict endothelial graft failure after penetrating keratoplasty.
        Arch Ophthalmol. 2010; 128: 63-69
        • Sugar A.
        • Gal R.L.
        • Kollman C.
        • et al.
        Writing Committee for the Cornea Donor Study Research Group. Factors predictive of corneal graft survival in the cornea donor study.
        JAMA Ophthalmol. 2015; 133: 246-254
        • Anshu A.
        • Chee S.P.
        • Mehta J.
        • Tan D.T.
        CMV endotheliitis in Descemet's stripping endothelial keratoplasty.
        Ophthalmology. 2009; 116: 624-633
        • Anshu A.
        • Lim L.S.
        • Htoon H.M.
        • Tan D.T.
        Postoperative risk factors influencing corneal graft survival in the Singapore Corneal Transplant Study.
        Am J Ophthalmol. 2011; 151: 442-448
        • Nguyen N.X.
        • Seitz B.
        • Martus P.
        • Langenbucher A.
        • Cursiefen C.
        Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty.
        Am J Ophthalmol. 2007; 144: 318-319
        • Shimazaki J.
        • Iseda A.
        • Satake Y.
        • Shimazaki-Den S.
        Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized clinical trial.
        Ophthalmology. 2012; 119: 668-673
        • Birnbaum F.
        • Mayweg S.
        • Reis A.
        • et al.
        Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study.
        Eye (Lond). 2009; 23: 2063-2070
        • Birnbaum F.
        • Böhringer D.
        • Sokolovska Y.
        • Sundmacher R.
        • Reinhard T.
        Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study.
        Transplantation. 2005; 79: 964-968
        • Han D.C.Y.
        • Mehta J.S.
        • Por Y.M.
        • Htoon H.M.
        • Tan D.T.H.
        Comparison of outcomes of lamellar keratoplasty and penetrating keratoplasty in keratoconus.
        Am J Ophthalmol. 2009; 148: 744-751
        • Lee W.B.
        • Jacobs D.S.
        • Musch D.C.
        • Kaufman S.C.
        • Reinhart W.J.
        • Shtein R.M.
        Descemet’s stripping endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology.
        Ophthalmology. 2009; 116: 1818-1830
        • Bahar I.
        • Kaiserman I.
        • Levinger E.
        • Sansanayudh W.
        • Slomovic A.R.
        • Rootman D.S.
        Retrospective contralateral study comparing Descemet stripping automated endothelial keratoplasty with penetrating keratoplasty.
        Cornea. 2009; 28: 485-488
        • Yuen L.H.
        • Mehta J.S.
        • Shilbayeh R.
        • Lim L.
        • Tan D.T.
        Hemi-automated lamellar keratoplasty (HALK).
        Br J Ophthalmol. 2011; 95: 1513-1518
        • Price M.O.
        • Calhoun P.
        • Kollman C.
        • Price Jr., F.W.
        • Lass J.H.
        Descemet stripping endothelial keratoplasty: ten-year endothelial cell loss compared with penetrating keratoplasty.
        Ophthalmology. 2016; 123: 1421-1427
        • Price M.O.
        • Gorovoy M.
        • Price Jr., F.W.
        • Benetz B.A.
        • Menegay H.J.
        • Lass J.H.
        Descemet's stripping automated endothelial keratoplasty: three-year graft and endothelial cell survival compared with penetrating keratoplasty.
        Ophthalmology. 2013; 120: 246-251